Sudhir Agrawal, TIBTECH, Oct. 1996, vol. 14, pp. 376-387.* |
Andrea D. Branch, TIBS 23—Feb., 1998.* |
Kuang-Yu Jen et al., Stem Cells 2000; 18: pp. 307-319.* |
Bouatrouss et al., “Altered Expression of Laminins in Crohn's Disease Small Intestinal Mucosa,” American Journal of Pathology 156(1):45-50, Jan. 2000. |
Karabulut et al., “Can alterations in integrin and laminin-5 expression be used as markers of malignancy?,” APMIS 106:1170-1180, 1998. |
Koshikawa et al., “Overexpression of Laminin γ2 Chain Monomer in Invading Gastric Carcinoma Cells,” Cancer Research 59:5596-5601, Nov. 1, 1999. |
Lohi et al., “Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for α3β1 integrin,” APMIS 108:161-172, 2000. |
Salo et al., “Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migration-related element in the γ2 chain gene (LAMC2) with activity in transgenic mice,” Matrix Biology 18:197-210, 1999. |
Skyldberg et al., “Laminin-5 as a Marker of Invasiveness in Cervical Lesions,” Journal of National Cancer Institute 91(21):1882-1887, Nov. 3, 1999. |